French medical device company Gecko Biomedical is celebrating the news that it has received new funding of 1.3 million Euros to invest in developing its ‘bio-inspired’ biodegradable surgical glues and patches for wound closure.
As the name hints, Gecko Biomedical takes nature as its inspiration for medical device development, particularly the seemingly self-adhesive little lizard family. The Paris-based company is privately owned and dedicated to the rapid development and the commercialization of revolutionary biodegradable sealants and adhesives for wound closure in the field of surgery, with a key focus on minimally invasive surgery.
Gecko Biomedical claims its development products are non-toxic, bind strongly to tissues and deliver ‘on-demand’ wound closure within the ‘wet’ and dynamic environments in the body.
The new funding is coming from Bpifrance, a subsidiary of the Caisse des Dépôts and the French Government, trusted partner of entrepeneurs, supports companies from seed to IPO stage. The funds are part of Bpifrance’s supports to innovation through its Aide au Développement de l’Innovation (ADI) program, providing repayable advances to encourage the development of innovative products.
These funds will be dedicated to advancing the manufacturing scale-up of Gecko Biomedical’s Liquid Film platform, and the completion of the non-clinical development plan for regulatory purposes.
Christophe Bancel, Gecko Biomedical’s Chief Executive Officer said “We are truly appreciative of Bpifrance’s support to our development activities. This ADI will allow us to swiftly advance the development program of Gecko Biomedical’s innovative adhesives. As such, Bpifrance is a key stakeholder in our short and medium term development.”
Bpi France comments
“Gecko Biomedical is a Parisian start-up whose innovation program presents multiple applications in the closure of surgical wounds in situ. In partnership with private investors, Bpi France is delighted to support Gecko Biomedical in the development of its innovative solutions with an international appeal”, comments Guillaume Poissonier, Innovation Manager from Bpi France.
Source: Gecko Biomedical